Talbot House Residential Stabilization
-
Services:
- TB screening
- Drug and alcohol oral fluid testing
- Testing for Hepatitis C (HCV)
- HIV testing
- Testing for Hepatitis B (HBV)
- Drug or alcohol urine screening
- STD testing
- Breathalyzer or blood alcohol testing
- Metabolic syndrome monitoring
- Case management service
- Mental health services
- Transportation assistance
- Acupuncture
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- In-network prescribing entity
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Substance use treatment
- In-network prescribing entity
- Male
- Female
- Mentoring/peer support
- Housing services
- Employment counseling or training
- Assistance with obtaining social services
- Self-help groups
- Nicotine replacement
- Naltrexone (oral)
- Disulfiram
- Clonidine
- Medication for mental disorders
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Acamprosate (Campral®)
- Medication routinely used during detoxification
- Alcohol Detoxification
- Opioids detoxification
- Cocaine Detoxification
- Methamphetamines detoxification
- Adult men
- Adult women
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Outcome follow-up after discharge
- Naloxone and overdose education
- Discharge Planning
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Hepatitis education, counseling, or support
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Individual counseling
- Young Adults
- Adults
- Trauma-related counseling
- Motivational interviewing
- Brief intervention
- Cognitive behavioral therapy
- 12-step facilitation
- Relapse prevention
- Substance use disorder counseling
- Telemedicine/telehealth therapy
- Federal, or any government funding for substance use treatment programs
- Private non-profit organization
- Vaping not permitted
- Comprehensive mental health assessment
- Screening for mental disorders
- Outreach to persons in the community
- Screening for substance use
- Interim services for clients
- Comprehensive substance use assessment
- Screening for tobacco use
- State Substance use treatment agency
- Residential/24-hour residential
- Residential detoxification
- Short-term residential
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Prescribes naltrexone
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Buprenorphine detoxification
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Smoking not permitted
Testing
Ancillary Services
External Opioid Medications Source
Type of Care
External Source of Medications Used for Alcohol Use Disorder Treatment
Gender Accepted
Recovery Support Services
Pharmacotherapies
Detoxification (medical withdrawal) Services
Special Programs/Groups Offered
Type of Alcohol Use Disorder Treatment
Transitional Services
Education and Counseling Services
Age Groups Accepted
Treatment Approaches
Payment/Insurance/Funding Accepted
Facility Operation (e.g., Private, Public)
Facility Vaping Policy
Assessment/Pre-treatment
License/Certification/Accreditation
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Opioid Treatment
Opioid Medications used in Treatment
Facility Smoking Policy